Diabetes Mellitus Clinical Trials in Jacksonville, Florida
4 studies are recruiting for diabetes mellitus in Jacksonville, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight and type 2 diabetes. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111 (the trea…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- Jacksonville Ctr Clin Res, Jacksonville, Florida
- Locations
- 74 in total
- Run by
- Novo Nordisk A/S
-
Inpatient Use of Personal Continuous Glucose Monitor (CGM) to Improve Diabetes Mellitus Control
The purpose of this research is to prove that data generated by your real-time personal continuous glucose monitors CGMs brought in the hospital at the time of hospitalization can be monitored and safely used to guide insulin therapy aiming to improve glycemic control and to diminish the hypoglycem…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mayo Clinic in Florida, Jacksonville, Florida
- Run by
- Mayo Clinic
-
Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients
The purpose of this study is to measure differences in diabetes control with the use of continuous glucose monitor (CGM) and diabetes education compared with standard of care for glucose monitoring (glucometer checks) and diabetes education in participants with diabetes mellitus receiving therapy w…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mayo Clinic in Florida, Jacksonville, Florida
- Run by
- Mayo Clinic
-
Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring
This study is to see if the FreeStyle Libre 3 Continuous Glucose Monitoring System (FSL3) will help prolong the length of time people with diabetes maintain adherence to glucagon-like peptide 1 (GLP-1/GIP) agonists.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- East Coast Institute for Research, LLC, Jacksonville, Florida
- Locations
- 2 in total
- Run by
- Abbott Diabetes Care
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.